المؤلفون: López-Codony V; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Programa de Doctorat en Biomedicina, Universitat de Barcelona (UB), Barcelona, Spain., de Andrés-Pablo Á; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Programa de Doctorat en Biomedicina, Universitat de Barcelona (UB), Barcelona, Spain., Ferrando-Díez A; Medical Oncology Department, Catalan Institute of Oncology, Germans Trias i Pujol University Hospital (HGTiP), Badalona, Barcelona, Spain., Fernández-Montolí ME; Department of Gynaecology, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain., López-Querol M; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain., Tous S; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain., Ortega-Expósito C; Department of Gynaecology, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain., Torrejón-Becerra JC; Department of Gynaecology, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain., Pérez Y; Department of Gynaecology, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain., Ferrer-Artola A; Bellvitge Biomedical Research Institute (IDIBELL), Pharmacy Unit, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain., Sole-Sedeno JM; Department of Obstetrics and Gynaecology, Hospital del Mar-Mar Health Park, Barcelona, Spain., Grau C; Sexual and Reproductive Health Care Center-ASSIR, Delta del Llobregat, Barcelona, Spain., Rupérez B; Sexual and Reproductive Health Care Center-ASSIR, Delta del Llobregat, Barcelona, Spain., Saumoy M; HIV and STD Unit, Bellvitge University Hospital (HUB), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Sánchez M; HIV and STD Unit, Bellvitge University Hospital (HUB), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Peremiquel-Trillas P; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Programa de Doctorat en Biomedicina, Universitat de Barcelona (UB), Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain., Bruni L; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain., Alemany L; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain., Bosch FX; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Faculty of Health Sciences, Open University of Catalonia (UOC), Barcelona, Spain., Pavón MA; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain.

المصدر: PloS one [PLoS One] 2024 May 20; Vol. 19 (5), pp. e0304080. Date of Electronic Publication: 2024 May 20 (Print Publication: 2024).

نوع المنشور: Journal Article; Clinical Trial Protocol

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Papillomavirus Infections*/prevention & control , Papillomavirus Infections*/virology , Papillomavirus Infections*/immunology , Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18*/administration & dosage , Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18*/immunology , Human papillomavirus 16*/immunology , Human papillomavirus 18*/immunology, Humans ; Female ; Adult ; Young Adult ; Adolescent ; Antibodies, Viral/immunology ; Papillomavirus Vaccines/administration & dosage ; Papillomavirus Vaccines/immunology ; DNA, Viral ; Vaccination/methods ; Cervix Uteri/virology

المؤلفون: Ivancic R; Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, U.S.A., Freeman T; Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, U.S.A., de Silva B; Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, U.S.A., Forrest A; Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, U.S.A., Kim B; Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, U.S.A., Matrka L; Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, U.S.A.

المصدر: The Laryngoscope [Laryngoscope] 2024 Jul; Vol. 134 (7), pp. 3226-3229. Date of Electronic Publication: 2024 Feb 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8607378 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-4995 (Electronic) Linking ISSN: 0023852X NLM ISO Abbreviation: Laryngoscope Subsets: MEDLINE

مواضيع طبية MeSH: Papillomavirus Infections*/prevention & control , Respiratory Tract Infections*/prevention & control , Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18*/administration & dosage, Humans ; Female ; Male ; Retrospective Studies ; Middle Aged ; Aged ; Aged, 80 and over ; Vaccination/statistics & numerical data ; Papillomavirus Vaccines/administration & dosage ; Adjuvants, Immunologic/administration & dosage ; Human Papillomavirus Viruses

SCR Disease Name: Recurrent respiratory papillomatosis

المؤلفون: Tomljenovic L; Children's Health Defense, Franklin Lakes, NJ, USA., McHenry LB; Department of Philosophy, California State University, Northridge, CA, USA.

المصدر: The International journal of risk & safety in medicine [Int J Risk Saf Med] 2024; Vol. 35 (2), pp. 159-180.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: IOSPress Country of Publication: Netherlands NLM ID: 9100907 Publication Model: Print Cited Medium: Internet ISSN: 1878-6847 (Electronic) Linking ISSN: 09246479 NLM ISO Abbreviation: Int J Risk Saf Med Subsets: MEDLINE

مواضيع طبية MeSH: Informed Consent*/ethics , Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18*/administration & dosage, Humans ; Denmark ; Placebos/administration & dosage ; Female ; Papillomavirus Vaccines/administration & dosage ; Papillomavirus Infections/prevention & control

المؤلفون: Davis BM; Arctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia., Blake I; Arctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA., Panicker G; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Meites E; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Thompson G; Arctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA., Geis J; Arctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA., Bruden D; Arctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA., Fischer M; Arctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA. Electronic address: mfischer@cdc.gov., Singleton R; Arctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA; Alaska Native Tribal Health Consortium, Anchorage, AK, USA., Unger ER; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Markowitz LE; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Bruce MG; Arctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA.

المصدر: Vaccine [Vaccine] 2024 May 22; Vol. 42 (14), pp. 3277-3281. Date of Electronic Publication: 2024 Apr 15.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Papillomavirus Infections*/prevention & control , Papillomavirus Infections*/immunology , Antibodies, Viral*/blood , Alaska Natives*/statistics & numerical data , Immunogenicity, Vaccine*, Humans ; Child ; Adolescent ; Female ; Male ; Alaska ; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/immunology ; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/administration & dosage ; Vaccination ; Immunoglobulin G/blood ; Papillomavirus Vaccines/immunology ; Papillomavirus Vaccines/administration & dosage

المؤلفون: Aga A; Unit of Otorhinolaryngology-Head and Neck Surgery, American Hospital, Rruga Lord Bajroni, Tirana, Albania. frediaga@gmail.com., Bekteshi E; Unit of Otorhinolaryngology-Head and Neck Surgery, American Hospital, Rruga Lord Bajroni, Tirana, Albania., Ajasllari G; Unit of Otorhinolaryngology-Head and Neck Surgery, American Hospital, Rruga Lord Bajroni, Tirana, Albania., Kosta A; Unit of Otorhinolaryngology-Head and Neck Surgery, American Hospital, Rruga Lord Bajroni, Tirana, Albania., Vajushi E; Unit of Otorhinolaryngology-Head and Neck Surgery, American Hospital, Rruga Lord Bajroni, Tirana, Albania., Kortoci R; Unit of Anaesthesiology, American Hospital, Tirana, Albania., Filauro M; Unit of Otorhinolaryngology-Head and Neck Surgery, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Muka T; Epistudia, 3008, Bern, Switzerland., Peretti G; Unit of Otorhinolaryngology-Head and Neck Surgery, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

المصدر: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2024 Jul; Vol. 281 (7), pp. 3693-3700. Date of Electronic Publication: 2024 Apr 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9002937 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-4726 (Electronic) Linking ISSN: 09374477 NLM ISO Abbreviation: Eur Arch Otorhinolaryngol Subsets: MEDLINE

مواضيع طبية MeSH: Papillomavirus Infections*/prevention & control , Respiratory Tract Infections*/prevention & control , Respiratory Tract Infections*/virology , Injections, Intralesional* , Bevacizumab*/therapeutic use , Bevacizumab*/administration & dosage, Humans ; Female ; Male ; Combined Modality Therapy ; Adult ; Laryngoscopy/methods ; Treatment Outcome ; Microsurgery/methods ; Young Adult ; Adolescent ; Papillomavirus Vaccines/administration & dosage ; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/administration & dosage

SCR Disease Name: Recurrent respiratory papillomatosis

المؤلفون: Oliveira IM; Universidade Federal de Goiás, Programa de Pós-Graduação em Ciências da Saúde, Goiânia, GO, Brazil., Martins BCT; Universidade Federal de Goiás, Programa de Pós-Graduação em Ciências da Saúde, Goiânia, GO, Brazil., Soares LR; Universidade Federal de Goiás, Programa de Pós-Graduação em Ciências da Saúde, Goiânia, GO, Brazil.

المصدر: Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil [Epidemiol Serv Saude] 2024 May 03; Vol. 33, pp. e2023895. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Secretaria de Vigilância em Saúde e Ambiente - Ministério da Saúde do Brasil Country of Publication: Brazil NLM ID: 101248287 Publication Model: eCollection Cited Medium: Internet ISSN: 2237-9622 (Electronic) Linking ISSN: 16794974 NLM ISO Abbreviation: Epidemiol Serv Saude Subsets: MEDLINE

مواضيع طبية MeSH: Papillomavirus Vaccines*/administration & dosage , Vaccination Coverage*/statistics & numerical data , Papillomavirus Infections*/prevention & control, Humans ; Female ; Brazil ; Adolescent ; Child ; Immunization Programs/statistics & numerical data ; Vaccination/statistics & numerical data ; Time Factors ; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/administration & dosage ; Human Papillomavirus Viruses

المؤلفون: Kitano T; Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Schwartz KL; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; Unity Health Toronto, St. Joseph Health Centre, Toronto, Ontario, Canada., Abdulnoor M; Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Garfield H; Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada., Booran NK; Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Avitzur Y; Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Teoh CW; Division of Nephrology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Hébert D; Division of Nephrology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Allen U; Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

المصدر: Pediatric transplantation [Pediatr Transplant] 2023 May; Vol. 27 (3), pp. e14476. Date of Electronic Publication: 2023 Feb 05.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9802574 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-3046 (Electronic) Linking ISSN: 13973142 NLM ISO Abbreviation: Pediatr Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18*/adverse effects , Liver Transplantation* , Papillomavirus Infections*/prevention & control , Papillomavirus Vaccines*/therapeutic use , Kidney Transplantation*, Child ; Female ; Humans ; Antibodies, Viral ; Human Papillomavirus Viruses ; Transplant Recipients ; Immunocompromised Host

المؤلفون: Peng Q; Department of Immunology, Zunyi Medical University, Zunyi 563000, China., Li Y; Department of Immunology, Zunyi Medical University, Zunyi 563000, China., Li J; Department of Immunology, Zunyi Medical University, Zunyi 563000, China., Yao X; Department of Immunology, Zunyi Medical University, Zunyi 563000, China. *Corresponding author, E-mail: immunology01@126.com.

المصدر: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology [Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi] 2024 Apr; Vol. 40 (4), pp. 378-382.

نوع المنشور: Journal Article; Review; English Abstract

بيانات الدورية: Publisher: Xi bao yu fen zi mian yi xue za zhi bian ji bu Country of Publication: China NLM ID: 101139110 Publication Model: Print Cited Medium: Print ISSN: 1007-8738 (Print) Linking ISSN: 10078738 NLM ISO Abbreviation: Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: Papillomavirus Vaccines*/immunology , Papillomavirus Vaccines*/administration & dosage , T-Lymphocytes*/immunology , B-Lymphocytes*/immunology, Humans ; Female ; Papillomavirus Infections/prevention & control ; Papillomavirus Infections/immunology ; Papillomavirus Infections/virology ; Vaccination ; Uterine Cervical Neoplasms/prevention & control ; Uterine Cervical Neoplasms/immunology ; Uterine Cervical Neoplasms/virology ; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/immunology ; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/administration & dosage ; Human Papillomavirus Viruses

المؤلفون: Zaman K; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Schuind AE; PATH, Center for Vaccine Innovation and Access, Seattle, Washington, United States. Electronic address: aschuind@path.org., Adjei S; Malaria Research Center, Agogo Presbyterian Hospital/Kwame Nkrumah University of Science and Technology, Agogo, Ghana., Antony K; PATH, Center for Vaccine Innovation and Access, Seattle, Washington, United States., Aponte JJ; PATH, Center for Vaccine Innovation and Access, Seattle, Washington, United States., Buabeng PB; Malaria Research Center, Agogo Presbyterian Hospital/Kwame Nkrumah University of Science and Technology, Agogo, Ghana., Qadri F; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Kemp TJ; HPV Serology Laboratory, Vaccine, Immunity, and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States., Hossain L; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Pinto LA; HPV Serology Laboratory, Vaccine, Immunity, and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States., Sukraw K; PATH, Center for Vaccine Innovation and Access, Seattle, Washington, United States., Bhat N; PATH, Center for Vaccine Innovation and Access, Seattle, Washington, United States., Agbenyega T; Malaria Research Center, Agogo Presbyterian Hospital/Kwame Nkrumah University of Science and Technology, Agogo, Ghana.

المصدر: Vaccine [Vaccine] 2024 Apr 02; Vol. 42 (9), pp. 2290-2298. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Papillomavirus Infections*/prevention & control , Papillomavirus Vaccines*, Female ; Humans ; Child ; Adolescent ; Young Adult ; Adult ; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/adverse effects ; Antibodies, Viral ; Vaccination ; Immunogenicity, Vaccine

المؤلفون: Yamaguchi M; School of Medicine, Kumamoto University, Kumamoto, Japan., Mtali YS; Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan., Sonokawa H; School of Medicine, Kumamoto University, Kumamoto, Japan., Takashima K; Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan., Fukushima Y; Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan., Kouwaki T; Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan., Oshiumi H; Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

المصدر: Microbiology and immunology [Microbiol Immunol] 2024 Feb; Vol. 68 (2), pp. 65-74. Date of Electronic Publication: 2023 Dec 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 7703966 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1348-0421 (Electronic) Linking ISSN: 03855600 NLM ISO Abbreviation: Microbiol Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Papillomavirus Infections*/prevention & control , Papillomavirus Vaccines*/genetics, Humans ; Animals ; Mice ; Cytokines ; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 ; Tumor Necrosis Factor-alpha ; Interleukin-6/genetics ; Trained Immunity ; Aluminum ; Adjuvants, Immunologic ; Toll-Like Receptors